Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort Study

被引:7
作者
Beltran, Leonora [1 ]
Gonzalez-Trejo, Sagrario [1 ]
Darlene Carmona-Herrera, Doris [1 ]
Carrillo, Jose F. [1 ]
Herrera-Goepfert, Roberto [1 ]
Aiello-Crocifoglio, Vincenzo [1 ]
Gallardo-Rincon, Dolores [1 ]
Melendez-Ponce, Norma A. [1 ]
Ochoa-Carrillo, Francisco J. [1 ]
Onate-Ocana, Luis F. [1 ]
机构
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
关键词
Colon cancer; Right colon cancer; Left colon cancer; Prognostic factors; Outcome assessment; COLORECTAL-CANCER; COMPLICATIONS; STATISTICS; MICROBIOTA;
D O I
10.1016/j.arcmed.2019.05.011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Right-colon cancer (RCC) presents differences with Left-colon cancer (LCC) in terms of Overall survival (OS), but certain reports provide conflicting findings. Our objective is to define differences regarding prognostic factors in RCC and LCC by multivariate analysis. Methods. Retrospective cohort including patients treated from 1992-2016. The Kaplan-Meier and Cox models were used to define prognostic factors. Results. 871 patients had RCC and 748 LCC; mean age was 58.1. Location was associated with socioeconomic status, body mass, blood hemoglobin, serum albumin, lymphocyte count and Prognostic nutritional index (PM). Distribution of TNM stages was similar between groups, as well as gender, age, surgical morbidity/mortality; 72.3% of RCC and 83.2% of LCC were well/moderately differentiated (p <0.0001). Mean surgical lymph-node retrieval was 19.3 (SD14.6) for RCC and 15.7 (SD13.1) for LCC (p <0.0001). Median OS was 5.2 (95% CI 3.9-6.5) for RCC, and 3.2 years (95% CI 2.1-4.4) for LCC (p = 0.426). OS was different between RCC and LCC by stratified analyses within PM, TNM, differentiation and R classification. RCC presents different OS in stages IIIC, and IVB than LCC. Conclusion. Differences between RCC and LCC were mainly by immunonutritional variables. Differences in OS were found after stratified analysis of PNI, TNM stages, differentiation degree, and R classification. Location of the neoplasm in the colon should be considered in the design of clinical trials in patients with colon cancer (C). 2019 IMSS. Published by Elsevier Inc.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 25 条
[1]   Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials [J].
Arnold, D. ;
Lueza, B. ;
Douillard, J. -Y. ;
Peeters, M. ;
Lenz, H. -J. ;
Venook, A. ;
Heinemann, V. ;
Van Cutsem, E. ;
Pignon, J. -P. ;
Tabernero, J. ;
Cervantes, A. ;
Ciardiello, F. .
ANNALS OF ONCOLOGY, 2017, 28 (08) :1713-1729
[2]   Colon carcinoma - Classification into right and left sided cancer or according to colonic subsite? - Analysis of 29 568 patients [J].
Benedix, F. ;
Schmidt, U. ;
Mroczkowski, P. ;
Gastinger, I. ;
Lippert, H. ;
Kube, R. .
EJSO, 2011, 37 (02) :134-139
[3]   Rectal Cancer, Version 2.2015 Featured Updates to the NCCN Guidelines [J].
Benson, Al B., III ;
Venook, Alan P. ;
Bekaii-Saab, Tanios ;
Chan, Emily ;
Chen, Yi-Jen ;
Cooper, Harry S. ;
Engstrom, Paul F. ;
Enzinger, Peter C. ;
Fenton, Moon J. ;
Fuchs, Charles S. ;
Grem, Jean L. ;
Grothey, Axel ;
Hochster, Howard S. ;
Hunt, Steven ;
Kamel, Ahmed ;
Kirilcuk, Natalie ;
Leong, Lucille A. ;
Lin, Edward ;
Messersmith, Wells A. ;
Mulcahy, Mary F. ;
Murphy, James D. ;
Nurkin, Steven ;
Rohren, Eric ;
Ryan, David P. ;
Saltz, Leonard ;
Sharma, Sunil ;
Shibata, David ;
Skibber, John M. ;
Sofocleous, Constantinos T. ;
Stoffel, Elena M. ;
Stotsky-Himelfarb, Eden ;
Willett, Christopher G. ;
Gregory, Kristina M. ;
Freedman-Cass, Deborah .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (06) :719-728
[4]   COLORECTAL-CANCER - EVIDENCE FOR DISTINCT GENETIC CATEGORIES BASED ON PROXIMAL OR DISTAL TUMOR LOCATION [J].
BUFILL, JA .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (10) :779-788
[5]   The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials [J].
Cascinu, S. ;
Poli, D. ;
Zaniboni, A. ;
Lonardi, S. ;
Labianca, R. ;
Sobrero, A. ;
Rosati, G. ;
Di Bartolomeo, M. ;
Scartozzi, M. ;
Zagonel, V. ;
Pella, N. ;
Banzi, M. ;
Torri, V. .
EUROPEAN JOURNAL OF CANCER, 2019, 111 :1-7
[6]   The Clavien-Dindo Classification of Surgical Complications Five-Year Experience [J].
Clavien, Pierre A. ;
Barkun, Jeffrey ;
de Oliveira, Michelle L. ;
Vauthey, Jean Nicolas ;
Dindo, Daniel ;
Schulick, Richard D. ;
de Santibanes, Eduardo ;
Pekolj, Juan ;
Slankamenac, Ksenija ;
Bassi, Claudio ;
Graf, Rolf ;
Vonlanthen, Rene ;
Padbury, Robert ;
Cameron, John L. ;
Makuuchi, Masatoshi .
ANNALS OF SURGERY, 2009, 250 (02) :187-196
[7]   Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer [J].
Dienstmann, Rodrigo ;
Vermeulen, Louis ;
Guinney, Justin ;
Kopetz, Scott ;
Tejpar, Sabine ;
Tabernero, Josep .
NATURE REVIEWS CANCER, 2017, 17 (02) :79-92
[8]  
Edge S.B., 2010, AJCC cancer staging manual, V649
[9]  
Ferlay J., 2013, IARC CancerBase
[10]  
Glebov OK, 2003, CANCER EPIDEM BIOMAR, V12, P755